Home » Newsletters » BioWorld Science

BioWorld Science

May 4, 1998

View Archived Issues

Pfizer synthesizes dual ORL1 antagonists/opioid receptor agonists

Bayer's potassium channel ligands for cognition disorders

DepoTech: Q1 1998 highlights

Pharmacological profile of PST-2238, a novel, orally active antihypertensive agent

GelTex: Q1 1998 highlights

Novel iNOS inhibitors developed by Nippon Kayaku

NeoRx receives SBIR grant for development of Pretarget technology

Progenitor receives patent protection for stem cell technology

Company Profile: TerraGen Diversity

Martek Biosciences issued European patent for DHA-rich oils

Sonus meets with FDA to clarify EchoGen NDA

BTG licenses antifungal agents to Race Pharmaceuticals

Topical BCX-34 not effective in phase II

QLT and Bard collaborate on development of system for restenosis

Chiroscience submits NDA to FDA for Chirocaine

Nebulized furosemide beneficial in patients with acute asthma of short-term duration

Mechanism of cardioprotective effect of LXR-015-2 postulated

Inhibitors of HRV 2A protease discovered by Lilly

Delsys to develop oral formulations of Parke-Davis drugs

Novel diabetes collaboration formed by OSI and Vanderbilt University

Efficacy of racemic form of LY-300164 in clonic status epilepticus

Biomira initiates bridging study of Theratope cancer vaccine

Multiple mechanisms involved in neuroprotective effects of dexanabinol

Immunomedics awarded two U.S. patents for Dx and Rx methods

Parkinson's disease symptoms improve in Spheramine preclinical trial

XR-300: in vitro and in vivo characterization of new antiplatelet/antithrombotic agent

FDA grants accelerated approval for Xeloda

FDA advisory committee recommends approval of Aggrastat

FDA clears CRYOcare surgical system to treat BPH

Another statin approved for stroke prevention indications

Development update for CFC-222

FDA advisory committee votes against approval of tocolytic

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...